Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1994-11-23
1997-09-09
Stone, Jacqueline M.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 937, A61K 4800, C12N 508
Patent
active
056653506
ABSTRACT:
Methods for the enhancement of bone marrow stem cell engraftment are provided for use in transplantation therapy and ex vivo gene therapy of a mammal. The methods involve the transplantation of quiescent stem cells for transplantation therapy and quiescent transfected stem cells for ex vivo gene therapy.
REFERENCES:
patent: 4396601 (1983-08-01), Salser et al.
patent: 5032407 (1991-07-01), Wagner et al.
patent: 5061620 (1991-10-01), Tsukamoto et al.
patent: 5437994 (1995-08-01), Emerson et al.
Marshall, Science, 269, 1995, 1004-1012.
Harrison, Blood, 81 (10), 1993, 2473-2474.
Stewart et al., 81 (10), 1993, 2566-2571.
Kohn, Curr. Opin. Pediatrics, 1995, 7, 56-63.
Gutierrez et al., The Lancet, vol. 339, 1992, 715-721.
Marshall, Science, 269, 1995, 1050-1055.
Miller et al., FASEBJ., 1994, 9, 190-199.
Culver et al., Trends Genetics, 10(5), 1994, 174-178.
Hodgson, Exp. Opin. Ther. Pat., 5(5), 1995, 459-468.
Barlogie, B.,"Hemopoietic stem cell transplant for multiple myeloma (MM)", 1993,Leukemia, 7:1095.
Biron, P. et al., "Autologous Bone Marrow Transplantation:Proceedings of the First International Symposium", Dicke, K.A. et al., eds, pp. 203-210; Massive Chemotherapy and Autologous Bone Marrow Transplantation in Progressive Disease of Nonseminomatous Testicular Cancer:A Phase II Study on 15 patients, 1985.
Breacher, G. et al., "Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice", 1982, PNAS USA 79:5085-5087.
Cheson, B.D. et al., "Autologous bone marrow transplantation. Current status and future directions", 1989, Ann. Intern. Med. 110(1):51-65.
Crittenden, R. et al., "Repetitive Marrow Transplantation:A Model for Autologous Gene Therapy", 1993, Experimental, Hematology, 21:1016, abstract 30.
Peters, S.Q. et al., "Cytokine Incubation of Murine Marrow Cells Impairs Repopulating Capacity in normal (Non-myeloablated) Hosts", 1994, Experimental Hematology, 22(8):823, abstract 547.
Peters, W. P., "The Rationale for High-Dose Chemotherapy with Autologous Bone Marrow Support in Treating Breast Cancer", 1985, AMBT supra, pp. 189-195.
Ramshaw, H.S. et al.,"Effect of cell cycle on the engraftment of murine bone marrow into unmyeloablated hosts", 1994, Experimental Hematology, 22:823, abstract 548.
Saxe, D.F. et al., "Transplantation of Chromosomally Marked Syngeneic Marrow Cells into Mice Not Subjected to Hematopietic Stem Cells Depletion", 1984, Exp. Hematol. 12:277-283.
Stewart et al., "Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice", 1993, Blood 81(10):2566-2571.
Sullivan, K.M., "Marrow transplantation for disorders of hematopoiesis", 1993, Leukemia, 7:1098-1099.
Takvorian, T, et al., "Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkins's lymphoma with a poor prognosis", 1987, N. Engl. J. Med. 316:1499-1505.
Wheeler, C. et al., "Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphomna:a dose-finding study", 1990, J. Clin. Oncol. 8(4):648-656.
Yeager, A.M. et al., "Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide", 1986, N. Eng. J. Med. 315(3:141-147.
Milne Andrew
Stone Jacqueline M.
University of Massachusetts Medical Center
LandOfFree
Cell cycle dependent transplantation and ex vivo gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell cycle dependent transplantation and ex vivo gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell cycle dependent transplantation and ex vivo gene therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-67540